Vivodyne's AI experiments on lab-grown human tissue could soon replace the need to test drugs on mice or dogs—and the approach has the potential to create drugs that work better.

Tool count used to be the consolidation scorecard. In 2026, it's data gravity — and it's dragging CDP vendors toward a reckoning. A marketing team's data stack works a lot like a building's plumbing.